$ATRA Atara Biotherapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Atara Biotherapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Atara Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atara Biotherapeutics, Inc. for free.

CIK Number: 0001604464
IRS Number: 460920988
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ATRA
Company Address: 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO 94080

Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.

Market Capitalization: $434.34M
Prev close: $15.05
Average Daily Volume: 231,402
Days Low: $14.70
Year Low: $12.45
Year High: $25.73

Atara Biotherapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ciechanover Isaac E.Chief Executive Officer202,4783,047,294shares bought: 595,292 / shares sold: -814,157 SELLApr 12 201810 days ago
Clark Mitchall G.EVP & Chief R & QA Officer133,6712,011,749shares bought: 204,946 / shares sold: -154,739 BUYApr 03 201819 days ago
Fust Matthew KDirector32,106483,195shares bought: 18,218 / shares sold: 0 STRONG BUYFeb 20 20182 months ago
Gallagher Carol GiltnerDirector111,2861,674,854shares bought: 25,926 / shares sold: -9,286 STRONG BUYFeb 20 20182 months ago
Haqq ChristopherEVP, R&D & Chief Scientific Of334,0055,026,775shares bought: 163,357 / shares sold: -125,692 BUYMar 27 201826 days ago
Kim MinaSenior VP & General Counsel42,500639,625shares bought: 170,000 / shares sold: 0 STRONG BUYApr 09 201813 days ago
MCGRATH JOHNEVP & Chief Financial Officer91,7621,381,018shares bought: 175,667 / shares sold: -138,619 BUYMar 20 20181 month ago
Newell JoeChief Tech. Operations Officer31,858479,463shares bought: 32,500 / shares sold: -642 STRONG BUYApr 04 201818 days ago
Porter DerrellSVP, Head of Global Commercial14,044211,362shares bought: 12,500 / shares sold: 0 BUYFeb 08 20182 months ago
Sofer GadEVP & Chief Strategy Officer268,3444,038,577shares bought: 218,600 / shares sold: -78,104 STRONG BUYFeb 20 20182 months ago
Turner Heather DFormer EVP, GC & Sec.77,1121,160,536shares bought: 49,500 / shares sold: -16,648 BUYFeb 12 20182 months ago

View all Atara Biotherapeutics, Inc. insiders.

Atara Biotherapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 12 2018ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS43.691,20052,428197,678198.9 K to 197.7 K (-0.60 %)
Apr 12 2018ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS42.633,200136,416198,878202.1 K to 198.9 K (-1.58 %)
Apr 12 2018ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS41.3740016,548202,078202.5 K to 202.1 K (-0.20 %)
Apr 12 2018ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS40.774,000163,080202,478206.5 K to 202.5 K (-1.94 %)
Apr 09 2018ATRAAtara Biotherapeut ...Kim MinaSenior VP & General ...Option ExerciseA36.0070,0002,520,00070,000
Apr 09 2018ATRAAtara Biotherapeut ...Kim MinaSenior VP & General ...Option ExerciseA36.0070,0002,520,00070,000
Apr 09 2018ATRAAtara Biotherapeut ...Kim MinaSenior VP & General ...GrantA0.0042,500042,5000 to 42.5 K
Apr 09 2018ATRAAtara Biotherapeut ...Kim MinaSenior VP & General ...GrantA0.0042,500042,5000 to 42.5 K
Apr 04 2018ATRAAtara Biotherapeut ...Newell JoeChief Tech. Operati ...Payment of ExerciseF36.2564223,27331,85832.5 K to 31.9 K (-1.98 %)
Apr 03 2018ATRAAtara Biotherapeut ...Clark Mitchall G.EVP & Chief R & QA ...SellS40.0722,400897,568133,671156.1 K to 133.7 K (-14.35 %)
Mar 28 2018ATRAAtara Biotherapeut ...Clark Mitchall G.EVP & Chief R & QA ...Option ExerciseM11.0011,406125,4663,125
Mar 28 2018ATRAAtara Biotherapeut ...Clark Mitchall G.EVP & Chief R & QA ...Option ExerciseM22.7232,500738,40032,500
Mar 28 2018ATRAAtara Biotherapeut ...Clark Mitchall G.EVP & Chief R & QA ...Option ExerciseM25.1528,848725,52711,194
Mar 28 2018ATRAAtara Biotherapeut ...Clark Mitchall G.EVP & Chief R & QA ...SellS41.1011,103456,333156,071167.2 K to 156.1 K (-6.64 %)
Mar 28 2018ATRAAtara Biotherapeut ...Clark Mitchall G.EVP & Chief R & QA ...SellS40.402,800113,120167,174170 K to 167.2 K (-1.65 %)

View all Atara Biotherapeutics, Inc. insider transactions.